Literature DB >> 26757202

Cerebellomedullary Cistern Delivery for AAV-Based Gene Therapy: A Technical Note for Nonhuman Primates.

Lluis Samaranch1, John Bringas1, Philip Pivirotto1, Waldy San Sebastian1, John Forsayeth1, Krystof Bankiewicz1.   

Abstract

Accessing cerebrospinal fluid (CSF) from the craniocervical junction through the posterior atlanto-occipital membrane via cerebellomedullary injection (also known as cisternal puncture or cisterna magna injection) has become a standard procedure in preclinical studies. Such delivery provides broader coverage to the central and peripheral nervous system unlike local parenchymal delivery alone. As a clinical application, this approach offers a more reliable method for neurological gene replacement delivery in infants, where skull-mounted devices are not indicated. Here we describe a consistent, precise, and safe method for CSF injection with minimal equipment and technical skills.

Entities:  

Mesh:

Year:  2016        PMID: 26757202      PMCID: PMC4761826          DOI: 10.1089/hgtb.2015.129

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  4 in total

1.  Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates.

Authors:  Lluis Samaranch; Ernesto A Salegio; Waldy San Sebastian; Adrian P Kells; Kevin D Foust; John R Bringas; Clementine Lamarre; John Forsayeth; Brian K Kaspar; Krystof S Bankiewicz
Journal:  Hum Gene Ther       Date:  2012-03-28       Impact factor: 5.695

2.  Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates.

Authors:  Lluis Samaranch; Ernesto A Salegio; Waldy San Sebastian; Adrian P Kells; John R Bringas; John Forsayeth; Krystof S Bankiewicz
Journal:  Hum Gene Ther       Date:  2013-05-02       Impact factor: 5.695

3.  AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigen-presenting cell transduction.

Authors:  Lluis Samaranch; Waldy San Sebastian; Adrian P Kells; Ernesto A Salegio; Gregory Heller; John R Bringas; Philip Pivirotto; Stephen DeArmond; John Forsayeth; Krystof S Bankiewicz
Journal:  Mol Ther       Date:  2013-11-21       Impact factor: 11.454

4.  Distribution of nanoparticles throughout the cerebral cortex of rodents and non-human primates: Implications for gene and drug therapy.

Authors:  Ernesto A Salegio; Hillary Streeter; Nikhil Dube; Piotr Hadaczek; Lluis Samaranch; Adrian P Kells; Waldy San Sebastian; Yuying Zhai; John Bringas; Ting Xu; John Forsayeth; Krystof S Bankiewicz
Journal:  Front Neuroanat       Date:  2014-03-17       Impact factor: 3.856

  4 in total
  6 in total

1.  Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders.

Authors:  K Bey; C Ciron; L Dubreil; J Deniaud; M Ledevin; J Cristini; V Blouin; P Aubourg; M-A Colle
Journal:  Gene Ther       Date:  2017-04-20       Impact factor: 5.250

2.  A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna.

Authors:  Toloo Taghian; Miklos G Marosfoi; Ajit S Puri; Oguz I Cataltepe; Robert M King; Elise B Diffie; Anne S Maguire; Douglas R Martin; Deborah Fernau; Ana Rita Batista; Tim Kuchel; Chris Christou; Raj Perumal; Sundeep Chandra; Paul D Gamlin; Stephanie G Bertrand; Terence R Flotte; Diane McKenna-Yasek; Phillip W L Tai; Neil Aronin; Matthew J Gounis; Miguel Sena-Esteves; Heather L Gray-Edwards
Journal:  Mol Ther       Date:  2019-11-16       Impact factor: 11.454

Review 3.  Future Prospects of Gene Therapy for Friedreich's Ataxia.

Authors:  Gabriel Ocana-Santero; Javier Díaz-Nido; Saúl Herranz-Martín
Journal:  Int J Mol Sci       Date:  2021-02-11       Impact factor: 5.923

Review 4.  Gene Therapy for Lysosomal Storage Disorders: Ongoing Studies and Clinical Development.

Authors:  Giulia Massaro; Amy F Geard; Wenfei Liu; Oliver Coombe-Tennant; Simon N Waddington; Julien Baruteau; Paul Gissen; Ahad A Rahim
Journal:  Biomolecules       Date:  2021-04-20

Review 5.  Management of Neuroinflammatory Responses to AAV-Mediated Gene Therapies for Neurodegenerative Diseases.

Authors:  Barbara A Perez; Alison Shutterly; Ying Kai Chan; Barry J Byrne; Manuela Corti
Journal:  Brain Sci       Date:  2020-02-22

Review 6.  Translational Approaches for Brain Delivery of Biologics via Cerebrospinal Fluid.

Authors:  Shraddha S Sadekar; Mayumi Bowen; Hao Cai; Samira Jamalian; Hanine Rafidi; Whitney Shatz-Binder; Julien Lafrance-Vanasse; Pamela Chan; William J Meilandt; Amy Oldendorp; Alavattam Sreedhara; Ann Daugherty; Susan Crowell; Kristin R Wildsmith; Jasvinder Atwal; Reina N Fuji; Joshua Horvath
Journal:  Clin Pharmacol Ther       Date:  2022-02-23       Impact factor: 6.903

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.